When did Nurix Therapeutics, Inc. report Q1 2025 earnings?

Nurix Therapeutics, Inc. (NRIX) reported Q1 2025 earnings on April 8, 2025 before market open.

What were Nurix Therapeutics, Inc.'s Q1 2025 revenue and EPS?

Nurix Therapeutics, Inc. reported revenue of $18.5M and diluted EPS of $-0.67 for Q1 2025.

Revenue beat the consensus estimate of $15.8M by $2.6M. EPS beat the consensus estimate of $-0.72 by $0.05.

You can read the 10-Q periodic report (0001549595-25-000055) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported April 8, 2025 · Before market open

Revenue estimate$15.8M

EPS estimate-$0.72

Jul 9, 2026 (In 2 weeks)

Revenue estimate$15.9M

EPS estimate-$0.73

Q1 2025$18.5MBeat by $2.6M

Q1 2025-$0.67Beat by $0.05

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Nurix Therapeutics, Inc. report Q1 2025 earnings?: Nurix Therapeutics, Inc. (NRIX) reported Q1 2025 earnings on April 8, 2025 before market open.
What were Nurix Therapeutics, Inc.'s Q1 2025 revenue and EPS?: Nurix Therapeutics, Inc. reported revenue of $18.5M and diluted EPS of $-0.67 for Q1 2025.
Did Nurix Therapeutics, Inc. beat estimates in Q1 2025?: Revenue beat the consensus estimate of $15.8M by $2.6M. EPS beat the consensus estimate of $-0.72 by $0.05.
Where can I find Nurix Therapeutics, Inc.'s Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001549595-25-000055) directly on SEC EDGAR. The filing index links above go to sec.gov.